201 related articles for article (PubMed ID: 34402912)
1. Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer.
Zhao W; Zhu B; Hutchinson A; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Wang D; Shi J; Landi MT
J Natl Cancer Inst; 2022 Feb; 114(2):280-289. PubMed ID: 34402912
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.
Francisco-Cruz A; Rocha P; Reuben A; Krishnan SN; Das P; Chen R; Quek K; Li J; Parra ER; Solis LM; Barua S; Jiang M; Lazcano R; Chow CW; Behrens C; Gumb C; Little L; Fukuoka J; Kalhor N; Weissferdt A; Kadara H; Heymach JV; Swisher S; Sepesi B; Rao A; Moran C; Zhang J; Lee JJ; Fujimoto J; Futreal PA; Wistuba II; Peterson CB; Zhang J
Mod Pathol; 2023 Jan; 36(1):100028. PubMed ID: 36788067
[TBL] [Abstract][Full Text] [Related]
3. Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer.
Marisa L; Blum Y; Taieb J; Ayadi M; Pilati C; Le Malicot K; Lepage C; Salazar R; Aust D; Duval A; Blons H; Taly V; Gentien D; Rapinat A; Selves J; Mouillet-Richard S; Boige V; Emile JF; de Reyniès A; Laurent-Puig P
Clin Cancer Res; 2021 Sep; 27(17):4768-4780. PubMed ID: 34168047
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
[TBL] [Abstract][Full Text] [Related]
5. Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis.
Yu T; Gao X; Zheng Z; Zhao X; Zhang S; Li C; Liu G
Front Oncol; 2021; 11():744064. PubMed ID: 34722299
[TBL] [Abstract][Full Text] [Related]
6. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
7. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
[TBL] [Abstract][Full Text] [Related]
8. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
[TBL] [Abstract][Full Text] [Related]
9. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
Iglesia MD; Parker JS; Hoadley KA; Serody JS; Perou CM; Vincent BG
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27335052
[TBL] [Abstract][Full Text] [Related]
10. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
[TBL] [Abstract][Full Text] [Related]
12. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
13. Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.
Ran X; Xiao J; Zhang Y; Teng H; Cheng F; Chen H; Zhang K; Sun Z
Ther Adv Med Oncol; 2020; 12():1758835920977117. PubMed ID: 33425025
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
Quek K; Li J; Estecio M; Zhang J; Fujimoto J; Roarty E; Little L; Chow CW; Song X; Behrens C; Chen T; William WN; Swisher S; Heymach J; Wistuba I; Zhang J; Futreal A; Zhang J
Oncotarget; 2017 Mar; 8(13):21994-22002. PubMed ID: 28423542
[TBL] [Abstract][Full Text] [Related]
16. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
17. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
Kim M; Lee S; Lim S; Kim S
PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
[TBL] [Abstract][Full Text] [Related]
18. IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.
Xiang X; Liu Z; Zhang C; Li Z; Gao J; Zhang C; Cao Q; Cheng J; Liu H; Chen D; Cheng Q; Zhang N; Xue R; Bai F; Zhu J
Adv Sci (Weinh); 2021 Sep; 8(17):e2101230. PubMed ID: 34250753
[TBL] [Abstract][Full Text] [Related]
19. Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients.
Lin Z; Meng X; Wen J; Corral JM; Andreev D; Kachler K; Schett G; Chen X; Bozec A
Front Oncol; 2020; 10():596493. PubMed ID: 33344244
[TBL] [Abstract][Full Text] [Related]
20. A clonal expression biomarker associates with lung cancer mortality.
Biswas D; Birkbak NJ; Rosenthal R; Hiley CT; Lim EL; Papp K; Boeing S; Krzystanek M; Djureinovic D; La Fleur L; Greco M; Döme B; Fillinger J; Brunnström H; Wu Y; Moore DA; Skrzypski M; Abbosh C; Litchfield K; Al Bakir M; Watkins TBK; Veeriah S; Wilson GA; Jamal-Hanjani M; Moldvay J; Botling J; Chinnaiyan AM; Micke P; Hackshaw A; Bartek J; Csabai I; Szallasi Z; Herrero J; McGranahan N; Swanton C;
Nat Med; 2019 Oct; 25(10):1540-1548. PubMed ID: 31591602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
